José Javier Sánchez Fernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
José Javier Sánchez Fernández has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Amador López Granados
Cardiology Department, Hospital Universitario Reina Sofía, University of Córdoba, 14004 Córdoba, Spain
2 shared publications Cristina Ogayar Luque
Cardiology Department, Hospital Reina Sofia, Córdoba, Spain
2 shared publicationsDolores Mesa Rubio
Cardiology Department, Hospital Reina Sofia, Córdoba, Spain
2 shared publications- Dolores Mesa-Rubio
Heart Failure Unit, Cardiology Department, Reina Sofia University Hospital, 14004 Cordoba, Spain
2 shared publications - Elías Romo Peñas
Cardiology Department, Hospital Universitario Reina Sofía, University of Córdoba, 14004 Córdoba, Spain
2 shared publications - José López-Aguilera
Heart Failure Unit, Cardiology Department, Reina Sofia University Hospital, 14004 Cordoba, Spain
2 shared publications
Latest Publications
- Open Access
- 27 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 207
Hospitalizations for Major Cardiovascular Events in Patients Aged 75 Years or Older with Chronic Coronary Syndrome for the Whole Life Span
Background/Objectives: Limited information exists on the burden of major cardiovascular morbidity in elderly patients with chronic coronary syndrome (CCS). Our objective was to investigate the cumulative incidence of lifetime hospitalizations for major cardiovascular events (MCE) in patients aged 75 years or older with CCS and to identify clinical predictors of these events. Methods: All consecutive outpatients aged 75 years or older with CCS seen in two consultations at a tertiary hospital between 2000 and 2008 were included in a prospective study and followed until death. All MCEs requiring admission (hospitalizations for heart failure (HF), acute myocardial infarction, and stroke) were recorded, and the cumulative incidence of each event and the combination of all events was calculated, considering death without admission as a competing event. Results: A total of 414 patients were selected (mean age was 79 ± 4 years, 36% women). After a 22-year follow-up (median 7 years, p25–75 4–11), 198 patients (48%) experienced at least one MCE, the most common being hospitalization for HF (122 patients had 209 hospitalizations). The 10 and 20-year cumulative incidence was 41% (95% CI 36–46%) and 48% (43–53%) for any event. In multivariate analysis, independent predictors of hospitalization for MCE were hypertension (HR 1.58 [95% CI:1.15–2.18], p = 0.005), diabetes (HR 1.38 [1.03–1.85], p = 0.031), prior HF (HR 2.52 [1.59–4.01], p < 0.0005), and atrial fibrillation (HR:1.68 [1.13–2.50], p = 0.011). Conclusions: Nearly half of elderly patients with CCS were hospitalized for MCE during their lifetime. HF was the most common event. Several clinical variables could be useful to stratify the risk of events.
- 27 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 207
Open AccessHospitalizations for Major Cardiovascular Events in Patients Aged 75 Years or Older with Chronic Coronary Syndrome for the Whole Life Span
Background/Objectives: Limited information exists on the burden of major cardiovascular morbidity in elderly patients with chronic coronary syndrome (CCS). Our objective was to investigate the cumulative incidence of lifetime hospitalizations for major cardiovascular events (MCE) in patients aged 75 years or older with CCS and to identify clinical predictors of these events. Methods: All consecutive outpatients aged 75 years or older with CCS seen in two consultations at a tertiary hospital between 2000 and 2008 were included in a prospective study and followed until death. All MCEs requiring admission (hospitalizations for heart failure (HF), acute myocardial infarction, and stroke) were recorded, and the cumulative incidence of each event and the combination of all events was calculated, considering death without admission as a competing event. Results: A total of 414 patients were selected (mean age was 79 ± 4 years, 36% women). After a 22-year follow-up (median 7 years, p25–75 4–11), 198 patients (48%) experienced at least one MCE, the most common being hospitalization for HF (122 patients had 209 hospitalizations). The 10 and 20-year cumulative incidence was 41% (95% CI 36–46%) and 48% (43–53%) for any event. In multivariate analysis, independent predictors of hospitalization for MCE were hypertension (HR 1.58 [95% CI:1.15–2.18], p = 0.005), diabetes (HR 1.38 [1.03–1.85], p = 0.031), prior HF (HR 2.52 [1.59–4.01], p < 0.0005), and atrial fibrillation (HR:1.68 [1.13–2.50], p = 0.011). Conclusions: Nearly half of elderly patients with CCS were hospitalized for MCE during their lifetime. HF was the most common event. Several clinical variables could be useful to stratify the risk of events.
- Open Access
- 25 August 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (17) , 4987
The Role of Left Atrial Longitudinal Strain in the Diagnosis of Acute Cellular Rejection in Heart Transplant Recipients
Our aim was to investigate the role of left atrial longitudinal strain (LALS) in the non-invasive diagnosis of acute cellular rejection (ACR) episodes in heart transplant (HTx) recipients. Methods: We performed successive echocardiographic exams in 18 consecutive adult HTx recipients in their first year after HTx within 3 h of the routine surveillance endomyocardial biopsies (EMB) in a single center. LALS parameters were analyzed with two different software. We investigated LALS association with ACR presence, as well as inter-vendor variability in comparable LALS values. Results: A total of 147 pairs of EMB and echo exams were carried out. Lower values of LALS were significantly associated with any grade of ACR presence. Peak atrial longitudinal strain (PALS) offered the best diagnostic value for any grade of ACR, with a C statistic of 0.77 using one software (95% CI 0.68–0.84, p < 0.0005) and 0.64 with the other (95% CI 0.54–0.73, p = 0.013) (p = 0.02 for comparison between both curves). Reproducibility between comparable LALS parameters was poor (intraclass correlation coefficients were 0.60 for PALS, 95% CI 0.42–0.73, p < 0.0005; and 0.42 for PALS rate, 95% CI −0.13–0.68, p < 0.0005). Conclusions: LALS variables might be a sensitive marker of ACR in HTx recipients, principally discriminating between those studies without rejection and those with any grade of ACR. Inter-vendor variability was significant.
- 25 August 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (17) , 4987
Open AccessThe Role of Left Atrial Longitudinal Strain in the Diagnosis of Acute Cellular Rejection in Heart Transplant Recipients
Our aim was to investigate the role of left atrial longitudinal strain (LALS) in the non-invasive diagnosis of acute cellular rejection (ACR) episodes in heart transplant (HTx) recipients. Methods: We performed successive echocardiographic exams in 18 consecutive adult HTx recipients in their first year after HTx within 3 h of the routine surveillance endomyocardial biopsies (EMB) in a single center. LALS parameters were analyzed with two different software. We investigated LALS association with ACR presence, as well as inter-vendor variability in comparable LALS values. Results: A total of 147 pairs of EMB and echo exams were carried out. Lower values of LALS were significantly associated with any grade of ACR presence. Peak atrial longitudinal strain (PALS) offered the best diagnostic value for any grade of ACR, with a C statistic of 0.77 using one software (95% CI 0.68–0.84, p < 0.0005) and 0.64 with the other (95% CI 0.54–0.73, p = 0.013) (p = 0.02 for comparison between both curves). Reproducibility between comparable LALS parameters was poor (intraclass correlation coefficients were 0.60 for PALS, 95% CI 0.42–0.73, p < 0.0005; and 0.42 for PALS rate, 95% CI −0.13–0.68, p < 0.0005). Conclusions: LALS variables might be a sensitive marker of ACR in HTx recipients, principally discriminating between those studies without rejection and those with any grade of ACR. Inter-vendor variability was significant.
- 11 June 2020
- Published by Springer Nature in Journal of Neurology
- Vol. 267 (10) , 3061-3068
CHA2DS2-VASc score as predictor of stroke and all-cause death in stable ischaemic heart disease patients without atrial fibrillation
Background Cerebrovascular and coronary artery disease share risk factors. The aim was to study CHA2DS2-VASc score as predictor of stroke incidence and death in a sample of patients with sinus rhythm and stable ischemic heart disease (sIHD) during long-term follow-up. Methods 1184 patients with sIHD and without atrial fibrillation were included in this single-centre prospective cohort study between February 2000 and January 2004. Stroke and death prediction abilities of CHA2DS2-VASc score in this population were investigated. Results The median age was 66 (interquartile range (IQR), 60–73 years). The mean follow-up was 11.2 ± 10 years (maximum 17 years). Along this period, 137 patients (11.6% of the sample) suffered a stroke. The mean value of CHA2DS2-VASc score was 3.04 ± 1.36, with CHA2DS2-VASc score ≤ 4 in 85.5% of the sample. Higher CHA2DS2-VASc score at baseline was associated with higher risk of suffering stroke (Hazard Ratio = 1.36, 95% CI 1.20–1.54, p < 0,001) and all-cause death during follow-up (Hazard Ratio = 1.49, 95% CI 1.40–1.58, p < 0,001). Conclusions Higher CHA2DS2-VASc score values were associated with higher risk of stroke and all-cause mortality during long-term follow-up in this real-world sample of patients with sIHD in sinus rhythm.
- 11 June 2020
- Published by Springer Nature in Journal of Neurology
- Vol. 267 (10) , 3061-3068
CHA2DS2-VASc score as predictor of stroke and all-cause death in stable ischaemic heart disease patients without atrial fibrillation
Background Cerebrovascular and coronary artery disease share risk factors. The aim was to study CHA2DS2-VASc score as predictor of stroke incidence and death in a sample of patients with sinus rhythm and stable ischemic heart disease (sIHD) during long-term follow-up. Methods 1184 patients with sIHD and without atrial fibrillation were included in this single-centre prospective cohort study between February 2000 and January 2004. Stroke and death prediction abilities of CHA2DS2-VASc score in this population were investigated. Results The median age was 66 (interquartile range (IQR), 60–73 years). The mean follow-up was 11.2 ± 10 years (maximum 17 years). Along this period, 137 patients (11.6% of the sample) suffered a stroke. The mean value of CHA2DS2-VASc score was 3.04 ± 1.36, with CHA2DS2-VASc score ≤ 4 in 85.5% of the sample. Higher CHA2DS2-VASc score at baseline was associated with higher risk of suffering stroke (Hazard Ratio = 1.36, 95% CI 1.20–1.54, p < 0,001) and all-cause death during follow-up (Hazard Ratio = 1.49, 95% CI 1.40–1.58, p < 0,001). Conclusions Higher CHA2DS2-VASc score values were associated with higher risk of stroke and all-cause mortality during long-term follow-up in this real-world sample of patients with sIHD in sinus rhythm.
- 26 September 2018
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 72 (10) , 827-834
Long-term Survival in a Spanish Population With Stable Ischemic Heart Disease. The CICCOR Registry
- 26 September 2018
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 72 (10) , 827-834
Long-term Survival in a Spanish Population With Stable Ischemic Heart Disease. The CICCOR Registry